Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Cirrhosis
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    May 2023
  1. GU L, Zhu Y, Lee M, Nguyen A, et al
    Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
    Proc Natl Acad Sci U S A. 2023;120:e2300706120.
    >> Share

  2. ZHANG J, Ning Y, Zhu H, Rotile NJ, et al
    Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T(1)-weighted MRI.
    Proc Natl Acad Sci U S A. 2023;120:e2220036120.
    >> Share

    January 2023
  3. LUUKKONEN PK, Sakuma I, Gaspar RC, Mooring M, et al
    Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis.
    Proc Natl Acad Sci U S A. 2023;120:e2217543120.
    >> Share

    March 2022
  4. KAPS L, Huppertsberg A, Choteschovsky N, Klefenz A, et al
    pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.
    Proc Natl Acad Sci U S A. 2022;119:e2122310119.
    >> Share

    July 2021
  5. NISHIO T, Koyama Y, Liu X, Rosenthal SB, et al
    Immunotherapy-based targeting of MSLN(+) activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    April 2021
  6. NISHIMURA N, De Battista D, McGivern DR, Engle RE, et al
    Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    March 2021
  7. PICCOLO P, Ferriero R, Barbato A, Attanasio S, et al
    Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    December 2020
  8. YUEH MF, He F, Chen C, Vu C, et al
    Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.
    Proc Natl Acad Sci U S A. 2020;117:31259-31266.
    >> Share

    November 2020
  9. SCHIERWAGEN R, Dietrich P, Klein S, Uschner FE, et al
    beta-Arrestin2 is increased in liver fibrosis in humans and rodents.
    Proc Natl Acad Sci U S A. 2020;117:27082-27084.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016